These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17341539)

  • 21. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better patient persistence with once-daily bupropion compared with twice-daily bupropion.
    Stang P; Young S; Hogue S
    Am J Ther; 2007; 14(1):20-4. PubMed ID: 17303971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population.
    Stang P; Suppapanaya N; Hogue SL; Park D; Rigney U
    Am J Ther; 2007; 14(3):241-6. PubMed ID: 17515697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences among smokers receiving interventions for tobacco dependence in a medical setting.
    Croghan IT; Ebbert JO; Hurt RD; Hays JT; Dale LC; Warner N; Schroeder DR
    Addict Behav; 2009 Jan; 34(1):61-7. PubMed ID: 18814974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label trial of bupropion in the treatment of pathologic gambling.
    Black DW
    J Clin Psychopharmacol; 2004 Feb; 24(1):108-10. PubMed ID: 14709965
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bupropion SR for the therapy of tobacco dependence].
    Gołecki M
    Pneumonol Alergol Pol; 2004; 72(3-4):139-42. PubMed ID: 15757279
    [No Abstract]   [Full Text] [Related]  

  • 27. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant treatment and smoking cessation in bipolar disorder.
    Dervaux A; Laqueille X
    JAMA; 2009 May; 301(20):2093; author reply 2093. PubMed ID: 19470985
    [No Abstract]   [Full Text] [Related]  

  • 29. Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
    Patterson F; Schnoll RA; Wileyto EP; Pinto A; Epstein LH; Shields PG; Hawk LW; Tyndale RF; Benowitz N; Lerman C
    Clin Pharmacol Ther; 2008 Sep; 84(3):320-5. PubMed ID: 18388868
    [No Abstract]   [Full Text] [Related]  

  • 30. Clozapine-induced sialorrhea alleviated by bupropion--a case report.
    Stern RG; Bellucci D; Cursi-Vogel N; Hughley J; Elangovan N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1578-80. PubMed ID: 19800381
    [No Abstract]   [Full Text] [Related]  

  • 31. First drug for seasonal depression.
    FDA Consum; 2006; 40(5):7. PubMed ID: 17328102
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA approves antidepressant drug for treatment of seasonal depression.
    Mayo Clin Womens Healthsource; 2006 Nov; 10(11):3. PubMed ID: 17047562
    [No Abstract]   [Full Text] [Related]  

  • 33. Bupropion-induced hypomania in a patient with unipolar depression.
    Hussain H; Butt MA
    Aust N Z J Psychiatry; 2008 Aug; 42(8):746. PubMed ID: 18622783
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute dystonia resulting from abrupt bupropion discontinuation.
    Wang HY; Chou WJ; Huang TY; Hung CF
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):766-8. PubMed ID: 17218049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bupropion and chronic aphthous ulceration.
    Kast RE; Altschuler EL
    Arch Dermatol; 2005 Sep; 141(9):1167. PubMed ID: 16172322
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quit smoking is not just a matter or will].
    Duquet N
    J Pharm Belg; 2006; 61(4):105-10. PubMed ID: 17263191
    [No Abstract]   [Full Text] [Related]  

  • 37. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis.
    Siniscalchi A; Gallelli L; Tolotta GA; Loiacono D; De Sarro G
    Clin Ther; 2010 Nov; 32(12):2030-4. PubMed ID: 21118738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cessation of nail-biting and bupropion.
    Wadden P; Pawliuk G
    Can J Psychiatry; 1999 Sep; 44(7):709-10. PubMed ID: 10500877
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of Extended Release Bupropion on Unilateral Ultrabrief Electroconvulsive Therapy Seizure Parameters in Major Depressive Disorder.
    Rakesh G; Mischel NA; Gunderson-Falcone G; Anderson A; Copeland D; Szabo ST; Weiner RD
    J ECT; 2020 Dec; 36(4):e45-e46. PubMed ID: 32243338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.